Aemetis, Inc. (NASDAQ:AMTX) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $12.95.

Several analysts recently weighed in on the company. StockNews.com upgraded Aemetis to a "sell" rating in a research report on Wednesday, July 31st. Truist Financial restated a "hold" rating and set a $3.50 price objective (down from $4.00) on shares of Aemetis in a research report on Wednesday, July 31st. HC Wainwright restated a "buy" rating and set a $28.00 price objective on shares of Aemetis in a research report on Friday, August 2nd. UBS Group dropped their price objective on Aemetis from $8.25 to $7.75 and set a "buy" rating for the company in a research report on Monday, August 19th. Finally, Ascendiant Capital Markets dropped their target price on Aemetis from $20.00 to $19.00 and set a "buy" rating for the company in a research report on Tuesday, September 3rd.

Institutional Investors Weigh In On Aemetis

Several institutional investors and hedge funds have recently made changes to their positions in the stock. SG Americas Securities LLC acquired a new stake in Aemetis during the first quarter worth approximately $60,000. Rhumbline Advisers grew its stake in Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company's stock valued at $157,000 after acquiring an additional 50,528 shares during the period. Susquehanna Fundamental Investments LLC grew its stake in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company's stock valued at $379,000 after acquiring an additional 93,536 shares during the period. State Board of Administration of Florida Retirement System acquired a new stake in Aemetis in the first quarter valued at approximately $84,000. Finally, Bank of New York Mellon Corp acquired a new stake in Aemetis in the second quarter valued at approximately $306,000. Institutional investors and hedge funds own 27.02% of the company's stock.

Aemetis Price Performance

NASDAQ AMTX traded down $0.08 on Wednesday, reaching $2.92. The stock had a trading volume of 592,841 shares, compared to its average volume of 798,393. The firm has a fifty day moving average of $2.55 and a two-hundred day moving average of $3.16. Aemetis has a 1-year low of $2.10 and a 1-year high of $7.03. The company has a market cap of $129.64 million, a P/E ratio of -2.56 and a beta of 1.24.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The specialty chemicals company reported ($0.66) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.25). The business had revenue of $66.56 million during the quarter, compared to analysts' expectations of $75.37 million. During the same quarter last year, the company posted ($0.68) earnings per share. Research analysts predict that Aemetis will post -2.07 EPS for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.